✦ LIBER ✦

Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era : Findings from a large national database

✍ Scribed by Anita Kumar; Ann Vanderplas; Ann S. LaCasce; Maria A. Rodriguez; Allison L. Crosby; Eva Lepisto; Myron S. Czuczman; Auayporn Nademanee; Joyce Niland; Leo I. Gordon; Michael Millenson; Andrew D. Zelenetz; Jonathan W. Friedberg; Gregory A. Abel

Book ID: 112066925
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 182 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26588

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The addition of rituximab reduces the in

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma

✍ Zdravko Mitrovic; Martin Bast; Philip J. Bierman; Robert G. Bociek; Julie M. Vos 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

β2-microglobulin aberrations in diffuse

β2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system

✍ Ekaterina S. Jordanova; Sietske A. Riemersma; Katja Philippo; Ed Schuuring; Phil 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 233 KB

## Abstract Human leukocyte antigen (HLA) class I molecules are expressed on the surface of all nucleated cells and present antigenic peptides to cytotoxic T cells, thereby playing an important role in initiating the cellular anti‐tumor immune response. We previously reported that loss of HLA class

Impact of central nervous system (CNS) p

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature

✍ Hany R. Guirguis; Matthew C. Cheung; Mervat Mahrous; Eugenia Piliotis; Neil Beri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Kacey O'Rourke; Kirk Morris; Glen A. Kennedy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Matthew Hellmann; Jeffrey A. Barnes; Peter Hammerman; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Central nervous system involvement in in

Central nervous system involvement in intravascular large B-cell lymphoma: A retrospective analysis of 109 patients

✍ Kazuyuki Shimada; Takuhei Murase; Kosei Matsue; Masataka Okamoto; Naoaki Ichikaw 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB